Tachycardia surgery: Difference between revisions
Jump to navigation
Jump to search
/* Permanent Pacemakers That Automatically Detect and Pace to Terminate Tachycardias Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoe... |
Hardik Patel (talk | contribs) /* Permanent Pacemakers That Automatically Detect and Pace to Terminate Tachycardias Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoe... |
||
| Line 8: | Line 8: | ||
==Surgery== | ==Surgery== | ||
==2008 ACC/AHA/HRS Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities (DO NOT EDIT)<ref name="Epstein"> Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: 2820–2840. PMID 18483207 </ref>== | ==2008 ACC/AHA/HRS Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities (DO NOT EDIT)<ref name="Epstein"> Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: 2820–2840. PMID 18483207 </ref>== | ||
===Permanent Pacemakers That Automatically Detect and Pace to Terminate Tachycardias<ref name="Epstein"> Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: 2820–2840. PMID 18483207 </ref>=== | ===Permanent Pacemakers That Automatically Detect and Pace to Terminate Tachycardias (DO NOT EDIT)<ref name="Epstein"> Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: 2820–2840. PMID 18483207 </ref>=== | ||
{|class="wikitable" | {|class="wikitable" | ||
|- | |- | ||
|colspan="1" style="text-align:center; background:LightCoral"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (No Benefit) | |colspan="1" style="text-align:center; background:LightCoral"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (No Benefit) | ||
|- | |- | ||
|bgcolor="LightCoral"| <nowiki>"</nowiki>'''1.''' Permanent [[pacemaker|pacing]] is not indicated in the presence of an accessory pathway that has the capacity for rapid anterograde conduction. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | |bgcolor="LightCoral"| <nowiki>"</nowiki>'''1.''' Permanent [[pacemaker|pacing]] is not indicated in the presence of an accessory pathway that has the capacity for rapid anterograde conduction. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | ||
|} | |} | ||
| Line 20: | Line 20: | ||
| colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | | colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' Permanent [[pacemaker|pacing]] is reasonable for symptomatic recurrent [[supraventricular tachycardia]] that is reproducibly terminated by pacing when [[catheter ablation]] and/or drugs fail to control the [[arrhythmia]] or produce intolerable side effects. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' Permanent [[pacemaker|pacing]] is reasonable for symptomatic recurrent [[supraventricular tachycardia]] that is reproducibly terminated by pacing when [[catheter ablation]] and/or drugs fail to control the [[arrhythmia]] or produce intolerable side effects. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<ref name="pmid2578645">{{cite journal| author=Peters RW, Scheinman MM, Morady F, Jacobson L| title=Long-term management of recurrent paroxysmal tachycardia by cardiac burst pacing. | journal=Pacing Clin Electrophysiol | year= 1985 | volume= 8 | issue= 1 | pages= 35-44 | pmid=2578645 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2578645 }} </ref><ref name="pmid3687782">{{cite journal| author=Fisher JD, Johnston DR, Furman S, Mercando AD, Kim SG| title=Long-term efficacy of antitachycardia pacing for supraventricular and ventricular tachycardias. | journal=Am J Cardiol | year= 1987 | volume= 60 | issue= 16 | pages= 1311-6 | pmid=3687782 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3687782 }} </ref><ref name="pmid6204313">{{cite journal| author=Den Dulk K, Bertholet M, Brugada P, Bär FW, Demoulin JC, Waleffe A et al.| title=Clinical experience with implantable devices for control of tachyarrhythmias. | journal=Pacing Clin Electrophysiol | year= 1984 | volume= 7 | issue= 3 Pt 2 | pages= 548-56 | pmid=6204313 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6204313 }} </ref><ref name="pmid3728334">{{cite journal| author=Saksena S, Pantopoulos D, Parsonnet V, Rothbart ST, Hussain SM, Gielchinsky I| title=Usefulness of an implantable antitachycardia pacemaker system for supraventricular or ventricular tachycardia. | journal=Am J Cardiol | year= 1986 | volume= 58 | issue= 1 | pages= 70-4 | pmid=3728334 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3728334 }} </ref><ref name="pmid3605893">{{cite journal| author=Barold SS, Wyndham CR, Kappenberger LL, Abinader EG, Griffin JC, Falkoff MD| title=Implanted atrial pacemakers for paroxysmal atrial flutter. Long-term efficacy. | journal=Ann Intern Med | year= 1987 | volume= 107 | issue= 2 | pages= 144-9 | pmid=3605893 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3605893 }} </ref><nowiki>"</nowiki> | ||
|} | |} | ||
Revision as of 21:02, 5 November 2012
|
Tachycardia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tachycardia surgery On the Web |
|
American Roentgen Ray Society Images of Tachycardia surgery |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Surgery
2008 ACC/AHA/HRS Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities (DO NOT EDIT)[1]
Permanent Pacemakers That Automatically Detect and Pace to Terminate Tachycardias (DO NOT EDIT)[1]
| Class III (No Benefit) |
| "1. Permanent pacing is not indicated in the presence of an accessory pathway that has the capacity for rapid anterograde conduction. (Level of Evidence: C)" |
| Class IIa |
| "1. Permanent pacing is reasonable for symptomatic recurrent supraventricular tachycardia that is reproducibly terminated by pacing when catheter ablation and/or drugs fail to control the arrhythmia or produce intolerable side effects. (Level of Evidence: C)[2][3][4][5][6]" |
Pacing to Prevent Tachycardia[1]
| Class I |
| "1. Permanent pacing is indicated for sustained pause-dependent VT, with or without QT prolongation. (Level of Evidence: C) " |
| Class III (No Benefit) |
| "1. Permanent pacing is not indicated for frequent or complex ventricular ectopic activity without sustained VT in the absence of the long-QT syndrome. (Level of Evidence: C) " |
| "2. Permanent pacing is not indicated for torsade de pointes VT due to reversible causes. (Level of Evidence: A) " |
| Class IIa |
| "1. Permanent pacing is reasonable for high-risk patients with congenital long-QT syndrome. (Level of Evidence: C) " |
| Class IIb |
| "1. Permanent pacing may be considered for prevention of symptomatic, drug-refractory, recurrent atrial fibrillation in patients with coexisting SND. (Level of Evidence: B) " |
Sources
- The ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities [1]
References
- ↑ 1.0 1.1 1.2 1.3 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: 2820–2840. PMID 18483207
- ↑ Peters RW, Scheinman MM, Morady F, Jacobson L (1985). "Long-term management of recurrent paroxysmal tachycardia by cardiac burst pacing". Pacing Clin Electrophysiol. 8 (1): 35–44. PMID 2578645.
- ↑ Fisher JD, Johnston DR, Furman S, Mercando AD, Kim SG (1987). "Long-term efficacy of antitachycardia pacing for supraventricular and ventricular tachycardias". Am J Cardiol. 60 (16): 1311–6. PMID 3687782.
- ↑ Den Dulk K, Bertholet M, Brugada P, Bär FW, Demoulin JC, Waleffe A; et al. (1984). "Clinical experience with implantable devices for control of tachyarrhythmias". Pacing Clin Electrophysiol. 7 (3 Pt 2): 548–56. PMID 6204313.
- ↑ Saksena S, Pantopoulos D, Parsonnet V, Rothbart ST, Hussain SM, Gielchinsky I (1986). "Usefulness of an implantable antitachycardia pacemaker system for supraventricular or ventricular tachycardia". Am J Cardiol. 58 (1): 70–4. PMID 3728334.
- ↑ Barold SS, Wyndham CR, Kappenberger LL, Abinader EG, Griffin JC, Falkoff MD (1987). "Implanted atrial pacemakers for paroxysmal atrial flutter. Long-term efficacy". Ann Intern Med. 107 (2): 144–9. PMID 3605893.